Target intelligence / Profile preview

SERTA domain-containing protein 3 (SERTAD3)

Target
SERTAD3
Molecular classification
Transcription coactivator, Interferon-stimulated gene, Other
01

Overview

SERTA domain-containing protein 3 (SERTAD3) is a nuclear protein, encoded by the SERTAD3 gene, and member of the SERTA family of transcriptional coactivators[2][3]. It functions as an antiviral interferon-stimulated gene product, restricting replication of certain RNA viruses such as Zika virus (by promoting proteasomal degradation of viral capsid proteins in the nucleus) and influenza virus (by disrupting viral polymerase complex formation)[1][2][5]. SERTAD3 also plays a role in the late-phase response of Toll–like receptor (TLR) induced immune effector expression and may be upregulated in cancer cells, where it can influence cell proliferation by acting as a strong transcriptional coactivator[2][4][5]. No approved drugs are currently known to directly target SERTAD3, but small peptides derived from SERTAD3 with antiviral activity have been investigated in experimental models[1].

Other names
SERTA domain containing 3SERTAD3RBT1RPA-binding trans-activatorreplication protein-binding trans-activator
02

Mechanism of action

Antiviral activity via proteasomal degradation of viral capsid proteins; acts as a transcriptional coactivator for innate immunity genes and disrupts viral replication complexes[1][2][5]

03

Biological functions

Innate immunityAntiviral responseTranscriptional coactivationRegulation of DNA-templated transcription
04

Disease associations

CancerViral infection (notably Zika virus and influenza)Other

Beyond the preview

Go deeper on SERTA domain-containing protein 3 (SERTAD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SERTA domain-containing protein 3 (SERTAD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call